in this issue

ISSUE 24 // February 2020

in this issue

issue 24 // February 2020

Screening programmes are a useful way for practitioners to identify conditions early on, even before symptoms arise. Last year, the NHS was praised for its adult screening programmes, but the uptake of screening services is failing, or stagnating across the country. We find out if a more proactive approach could help to reverse this downward trend.


Also in this issue, we speak to Dr Eric Topol about the humanising potential of AI, enter a new world of surgical training with FundamentalVR, and examine the potential of a device that mimics the smelling power of dogs to identify chemical signatures of chronic diseases.


Plus, we investigate the rise of online chronic illness communities, explore alternatives to ethylene oxide sterilisation as health concerns threaten the future of the process, and talk clinical trial platforms with Medidata.


Finally, we examine the fallout from Bayer’s Essure contraceptive implant, and get the latest insight and analysis from GlobalData.


Eloise McLennan, editor

Go to article: Home | When Treatments Turn ToxicGo to article: In This Issue Go to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: NewsGo to article: Tricor SystemsGo to article: The Medical Industry BriefingGo to article: RPMC Lasers Go to article: Health screening: the need for a more proactive approachGo to article: Mi3 Medical IntelligenceGo to article: Can AI make healthcare more human?Go to article: Swisstec 3DGo to article: Combining virtual reality and touch for surgical training Go to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: A nose for trouble: the bio-sensor aiming to sniff out diseaseGo to article: PI Ceramic Company Insight Go to article: PI CeramicGo to article: Elcam MedicalGo to article: Empowerment vs deceit: the darker side of digital health communitiesGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: What’s the solution to the ethylene oxide crisis?Go to article: General PlasticsGo to article: Ocean Insight Company InsightGo to article: Ocean InsightGo to article: SanminaGo to article:  Q&A: talking clinical trial tech and acquisitions with MedidataGo to article: Caeleste Company Insight Go to article: CaelesteGo to article: Not very re-Essureing: how a contraceptive implant can ruin livesGo to article: Apple RubberGo to article: axxosGo to article: Lessons and leftover challenges from MDR preparationsGo to article: maxonGo to article: micrometal Go to article: Role of wearable sensors in the early diagnosis of Graft Versus Host DiseaseGo to article: MedtecLIVEGo to article: Predicting influenza outbreak using Fitbit wearable technologyGo to article: Schurter Go to article: ESMAGo to article: AccumoldGo to article: Potential use of light-degradable medical devices in gastrointestinal proceduresGo to article: Smiths InterconnectGo to article: Hernia meshes allegedly used without clinical evidenceGo to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: JenaValve advances TAVR programme with FDA breakthrough device designationGo to article: Deals in brief powered by GlobaldataGo to article: Micro Systems TechnologiesGo to article: The key list powered by GlobaldataGo to article: Abatek InternationalGo to article: EventsGo to article: Next Issue